Search research articles
Contact Us
Filters
Showing results (1-10 of 242) with videos related to
Page
of 25
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 9, 2019
Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections
Dee Shortridge, Robert K Flamm
Antimicrobial Agents and Chemotherapy
|
January 11, 2017
Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015
Helio S Sader, Mariana Castanheira, Robert K Flamm
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
February 12, 2014
Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)
Robert K Flamm, Helio S Sader, Ronald N Jones
Journal of Global Antimicrobial Resistance
|
November 23, 2016
In vitro activity of ceftaroline tested against isolates from the Asia-Pacific region and South Africa (2011)
Robert K Flamm, Ronald N Jones, Helio S Sader
Diagnostic Microbiology and Infectious Disease
|
March 4, 2014
Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011
Robert K Flamm, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
March 22, 2013
Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011)
Helio S Sader, Robert K Flamm, Ronald N Jones
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011
Helio S Sader, Robert K Flamm, Ronald N Jones
Antimicrobial Agents and Chemotherapy
|
February 6, 2013
Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011
Helio S Sader, Robert K Flamm, Ronald N Jones
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
August 7, 2013
Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010
Robert K Flamm, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
March 29, 2013
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010)
Helio S Sader, Robert K Flamm, Ronald N Jones
Page
of 25
Search research articles
Search
Showing results (1-10 of 242) with videos related to
Sort By:
Page
of 25
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
April 9, 2019
Comparative In Vitro Activities of New Antibiotics for the Treatment of Skin Infections
Dee Shortridge, Robert K Flamm
Antimicrobial Agents and Chemotherapy
|
January 11, 2017
Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015
Helio S Sader, Mariana Castanheira, Robert K Flamm
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
February 12, 2014
Ceftaroline activity tested against contemporary Latin American bacterial pathogens (2011)
Robert K Flamm, Helio S Sader, Ronald N Jones
Journal of Global Antimicrobial Resistance
|
November 23, 2016
In vitro activity of ceftaroline tested against isolates from the Asia-Pacific region and South Africa (2011)
Robert K Flamm, Ronald N Jones, Helio S Sader
Diagnostic Microbiology and Infectious Disease
|
March 4, 2014
Ceftaroline activity against organisms isolated from respiratory tract infections in USA hospitals: results from the AWARE Program, 2009-2011
Robert K Flamm, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
March 22, 2013
Antimicrobial activity of daptomycin tested against Gram-positive pathogens collected in Europe, Latin America, and selected countries in the Asia-Pacific Region (2011)
Helio S Sader, Robert K Flamm, Ronald N Jones
Antimicrobial Agents and Chemotherapy
|
May 1, 2013
Antimicrobial activity of ceftaroline tested against staphylococci with reduced susceptibility to linezolid, daptomycin, or vancomycin from U.S. hospitals, 2008 to 2011
Helio S Sader, Robert K Flamm, Ronald N Jones
Antimicrobial Agents and Chemotherapy
|
February 6, 2013
Antimicrobial activity of ceftaroline-avibactam tested against clinical isolates collected from U.S. Medical Centers in 2010-2011
Helio S Sader, Robert K Flamm, Ronald N Jones
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases
|
August 7, 2013
Spectrum and potency of ceftaroline against leading pathogens causing community-acquired respiratory tract and skin and soft tissue infections in Latin America, 2010
Robert K Flamm, Helio S Sader, Ronald N Jones
Diagnostic Microbiology and Infectious Disease
|
March 29, 2013
Antimicrobial activity of ceftaroline and comparator agents tested against bacterial isolates causing skin and soft tissue infections and community-acquired respiratory tract infections isolated from the Asia-Pacific region and South Africa (2010)
Helio S Sader, Robert K Flamm, Ronald N Jones
Page
of 25